| Recruiting | 2 | 40 | US | Ensitrelvir, ensitrelvir fumaric acid, Placebo | Timothy Henrich, Shionogi Inc. | Long COVID, Post Acute Sequelae of COVID-19, Post-Acute COVID-19 | 03/25 | 12/25 | | |
PLATCOV, NCT05041907: Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 |
|
|
| Recruiting | 2 | 3000 | RoW | Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™), Hydroxychloroquine, No treatment, Monoclonal antibodies, Fluoxetine, Molnupiravir, Sotrovimab, Ensitrelvir, Favipiravir, Ivermectin, Remdesivir | University of Oxford | COVID-19 | 01/27 | 01/27 | | |
